These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 32952127)

  • 21. The Cryo-EM STRUCTURE of Renal Amyloid Fibril Suggests Structurally Homogeneous Multiorgan Aggregation in AL Amyloidosis.
    Puri S; Schulte T; Chaves-Sanjuan A; Mazzini G; Caminito S; Pappone C; Anastasia L; Milani P; Merlini G; Bolognesi M; Nuvolone M; Palladini G; Ricagno S
    J Mol Biol; 2023 Sep; 435(18):168215. PubMed ID: 37516426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Antibody Light-Chain Linker Regulates Domain Orientation and Amyloidogenicity.
    Weber B; Hora M; Kazman P; Göbl C; Camilloni C; Reif B; Buchner J
    J Mol Biol; 2018 Dec; 430(24):4925-4940. PubMed ID: 30414962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methods to study the structure of misfolded protein states in systemic amyloidosis.
    Fändrich M; Schmidt M
    Biochem Soc Trans; 2021 Apr; 49(2):977-985. PubMed ID: 33929491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesenchymal stromal cells protect human cardiomyocytes from amyloid fibril damage.
    Lin Y; Marin-Argany M; Dick CJ; Redhage KR; Blancas-Mejia LM; Bulur P; Butler GW; Deeds MC; Madden BJ; Williams A; Wall JS; Dietz A; Ramirez-Alvarado M
    Cytotherapy; 2017 Dec; 19(12):1426-1437. PubMed ID: 29037943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations can cause light chains to be too stable or too unstable to form amyloid fibrils.
    Marin-Argany M; Güell-Bosch J; Blancas-Mejía LM; Villegas S; Ramirez-Alvarado M
    Protein Sci; 2015 Nov; 24(11):1829-40. PubMed ID: 26300552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic protein structures in normal function and pathologic misfolding in systemic amyloidosis.
    Lewkowicz E; Gursky O
    Biophys Chem; 2022 Jan; 280():106699. PubMed ID: 34773861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissection of the amyloid formation pathway in AL amyloidosis.
    Kazman P; Absmeier RM; Engelhardt H; Buchner J
    Nat Commun; 2021 Nov; 12(1):6516. PubMed ID: 34764275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barriers to Small Molecule Drug Discovery for Systemic Amyloidosis.
    Morgan GJ
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34208058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Conservative Point Mutation in a Dynamic Antigen-binding Loop of Human Immunoglobulin λ6 Light Chain Promotes Pathologic Amyloid Formation.
    Peterle D; Klimtchuk ES; Wales TE; Georgescauld F; Connors LH; Engen JR; Gursky O
    J Mol Biol; 2021 Dec; 433(24):167310. PubMed ID: 34678302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggregation of Full-length Immunoglobulin Light Chains from Systemic Light Chain Amyloidosis (AL) Patients Is Remodeled by Epigallocatechin-3-gallate.
    Andrich K; Hegenbart U; Kimmich C; Kedia N; Bergen HR; Schönland S; Wanker E; Bieschke J
    J Biol Chem; 2017 Feb; 292(6):2328-2344. PubMed ID: 28031465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Process of Amyloid Formation due to Monoclonal Immunoglobulins.
    Morgan GJ; Wall JS
    Hematol Oncol Clin North Am; 2020 Dec; 34(6):1041-1054. PubMed ID: 33099422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin light chain amyloid aggregation.
    Blancas-Mejia LM; Misra P; Dick CJ; Cooper SA; Redhage KR; Bergman MR; Jordan TL; Maar K; Ramirez-Alvarado M
    Chem Commun (Camb); 2018 Sep; 54(76):10664-10674. PubMed ID: 30087961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid state NMR assignments of a human λ-III immunoglobulin light chain amyloid fibril.
    Pradhan T; Annamalai K; Sarkar R; Hegenbart U; Schönland S; Fändrich M; Reif B
    Biomol NMR Assign; 2021 Apr; 15(1):9-16. PubMed ID: 32946005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoelectron microscopy and mass spectrometry for classification of amyloid deposits.
    Abildgaard N; Rojek AM; Møller HE; Palstrøm NB; Nyvold CG; Rasmussen LM; Hansen CT; Beck HC; Marcussen N
    Amyloid; 2020 Mar; 27(1):59-66. PubMed ID: 31752543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inherent Biophysical Properties Modulate the Toxicity of Soluble Amyloidogenic Light Chains.
    Maritan M; Romeo M; Oberti L; Sormanni P; Tasaki M; Russo R; Ambrosetti A; Motta P; Rognoni P; Mazzini G; Barbiroli A; Palladini G; Vendruscolo M; Diomede L; Bolognesi M; Merlini G; Lavatelli F; Ricagno S
    J Mol Biol; 2020 Feb; 432(4):845-860. PubMed ID: 31874151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.
    Kazman P; Vielberg MT; Pulido Cendales MD; Hunziger L; Weber B; Hegenbart U; Zacharias M; Köhler R; Schönland S; Groll M; Buchner J
    Elife; 2020 Mar; 9():. PubMed ID: 32151314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of concept.
    Ramirez-Alvarado M; Barnidge DR; Murray DL; Dispenzieri A; Marin-Argany M; Dick CJ; Cooper SA; Nasr SH; Ward CJ; Dasari S; Jiménez-Zepeda VH; Leung N
    Am J Hematol; 2017 Jun; 92(6):536-541. PubMed ID: 28295502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Internalisation of immunoglobulin light chains by cardiomyocytes in AL amyloidosis: what can biopsies tell us?
    Bézard M; Zaroui A; Kharoubi M; Lam F; Poullot E; Teiger E; Agbulut O; Damy T; Kordeli E
    Amyloid; 2024 Sep; 31(3):209-219. PubMed ID: 38973117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Substantial Structural Conversion of the Native Monomer Leads to in-Register Parallel Amyloid Fibril Formation in Light-Chain Amyloidosis.
    Lecoq L; Wiegand T; Rodriguez-Alvarez FJ; Cadalbert R; Herrera GA; Del Pozo-Yauner L; Meier BH; Böckmann A
    Chembiochem; 2019 Apr; 20(8):1027-1031. PubMed ID: 30565364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis.
    Manabe S; Iwasaki C; Hatano M; Kametani F; Yazaki M; Nitta K; Nagata M
    BMC Nephrol; 2018 Nov; 19(1):337. PubMed ID: 30466387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.